MyChart is not for medical emergencies. If you have a medical emergency, call 911.
If you need help with MyChart, call us at 1-844-442-4278.
Russell Szmulewitz, MD, is an expert in the treatment and management of prostate, bladder, kidney and testicular cancers. His clinical focus is on the treatment of patients with advanced prostate cancer, with particular expertise in the use of leading-edge hormonal, targeted, and immunotherapies. Dr. Szmulewitz works in close collaboration with urologists, radiation oncologists and geriatricians who also specialize in the care of prostate cancer patients.
His research bridges the clinic and laboratory and focuses on the process of prostate cancer metastasis. In particular, his research attempts to better define the steps involved in metastatic progression and evolution to castration resistance in prostate cancer, with the goal of developing targeted therapies for these processes. In addition, Dr. Szmulewitz’s laboratory is developing strategies to isolate and interrogate circulating tumor cells (CTC) to better understand the biology of prostate cancer, and eventually personalize care based on this individualized biology.
Dr. Szmulewitz is particularly involved in therapeutic development for prostate cancer. He is an investigator on many clinical research trials focusing on immunotherapy, anti-angiogenic and other novel targeted therapies for prostate cancer.
The University of Chicago Pritzker School of Medicine
Duchossois Center for Advanced Medicine (DCAM) - Hyde Park
To Refer a PatientRefer a Patient or call UCM Connect at 1-888-824-0200
UChicago Medicine prostate cancer experts answer questions about the latest prostate cancer treatments, hereditary factors that increase the risk for prostate cancer and advanced research under way to improve the diagnosis and treatment of prostate cancer.Watch Video Watch Video With Transcript